Correlation Between The Bond and Biotechnology Fund

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both The Bond and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining The Bond and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Bond Fund and Biotechnology Fund Class, you can compare the effects of market volatilities on The Bond and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in The Bond with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of The Bond and Biotechnology Fund.

Diversification Opportunities for The Bond and Biotechnology Fund

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between The and BIOTECHNOLOGY is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding The Bond Fund and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and The Bond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Bond Fund are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of The Bond i.e., The Bond and Biotechnology Fund go up and down completely randomly.

Pair Corralation between The Bond and Biotechnology Fund

Assuming the 90 days horizon The Bond Fund is expected to generate 0.04 times more return on investment than Biotechnology Fund. However, The Bond Fund is 26.16 times less risky than Biotechnology Fund. It trades about -0.46 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about -0.13 per unit of risk. If you would invest  1,800  in The Bond Fund on October 8, 2024 and sell it today you would lose (40.00) from holding The Bond Fund or give up 2.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

The Bond Fund  vs.  Biotechnology Fund Class

 Performance 
       Timeline  
Bond Fund 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days The Bond Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, The Bond is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

The Bond and Biotechnology Fund Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with The Bond and Biotechnology Fund

The main advantage of trading using opposite The Bond and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if The Bond position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.
The idea behind The Bond Fund and Biotechnology Fund Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk